The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients - PubMed (original) (raw)
The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients
O Lingjaerde et al. Acta Psychiatr Scand Suppl. 1987.
No abstract available
Similar articles
- Reliability and validity of the Korean version of UKU-SERS-Pat in patients with bipolar disorder.
Kim JH, Choi SW, Joe SH, Ha TH, Yoo HJ, Choi JE, Cha B, Ha K. Kim JH, et al. Nord J Psychiatry. 2008;62(6):496-502. doi: 10.1080/08039480801985229. Nord J Psychiatry. 2008. PMID: 18841509 - Drug-induced movement disorders.
Powers JM. Powers JM. Ariz Med. 1983 Jul;40(7):464-7. Ariz Med. 1983. PMID: 6138016 No abstract available. - Tardive dyskinesia and psychotropic drug history.
Simpson GM, Varga E, Lee JH, Zoubok B. Simpson GM, et al. Psychopharmacology (Berl). 1978 Jul 6;58(2):117-24. doi: 10.1007/BF00426893. Psychopharmacology (Berl). 1978. PMID: 28544 - Drugs for psychiatric disorders.
[No authors listed] [No authors listed] Treat Guidel Med Lett. 2013 Jun;11(130):53-64; quiz 2p following 64. Treat Guidel Med Lett. 2013. PMID: 23715100 Review. No abstract available. - Tardive dyskinesia and anticholinergic drugs.
Gardos G, Cole JO. Gardos G, et al. Am J Psychiatry. 1983 Feb;140(2):200-2. doi: 10.1176/ajp.140.2.200. Am J Psychiatry. 1983. PMID: 6129809 Review.
Cited by
- Estimation of a preliminary therapeutic reference range for children and adolescents with tic disorders treated with tiapride.
Fekete S, Egberts K, Preissler T, Wewetzer C, Mehler-Wex C, Romanos M, Gerlach M. Fekete S, et al. Eur J Clin Pharmacol. 2021 Feb;77(2):163-170. doi: 10.1007/s00228-020-03000-0. Epub 2020 Sep 28. Eur J Clin Pharmacol. 2021. PMID: 32986159 Free PMC article. - The efficacy of memantine in the treatment of civilian posttraumatic stress disorder: an open-label trial.
Hori H, Itoh M, Matsui M, Kamo T, Saito T, Nishimatsu Y, Kito S, Kida S, Kim Y. Hori H, et al. Eur J Psychotraumatol. 2021 Jan 15;12(1):1859821. doi: 10.1080/20008198.2020.1859821. Eur J Psychotraumatol. 2021. PMID: 33680346 Free PMC article. - Homeopathic Individualized Q-Potencies versus Fluoxetine for Moderate to Severe Depression: Double-Blind, Randomized Non-Inferiority Trial.
Adler UC, Paiva NM, Cesar AT, Adler MS, Molina A, Padula AE, Calil HM. Adler UC, et al. Evid Based Complement Alternat Med. 2011;2011:520182. doi: 10.1093/ecam/nep114. Epub 2011 Jun 8. Evid Based Complement Alternat Med. 2011. PMID: 19687192 Free PMC article. - Correlates of subjective and functional outcomes in outpatient clinic attendees with schizophrenia and schizoaffective disorder.
Hofer A, Rettenbacher MA, Widschwendter CG, Kemmler G, Hummer M, Fleischhacker WW. Hofer A, et al. Eur Arch Psychiatry Clin Neurosci. 2006 Jun;256(4):246-55. doi: 10.1007/s00406-005-0633-3. Epub 2005 Nov 29. Eur Arch Psychiatry Clin Neurosci. 2006. PMID: 16311896 - Risperidone versus typical antipsychotic medication for schizophrenia.
Kennedy E, Song F, Hunter R, Clarke A, Gilbody S. Kennedy E, et al. Cochrane Database Syst Rev. 2000;2003(2):CD000440. doi: 10.1002/14651858.CD000440. Cochrane Database Syst Rev. 2000. PMID: 10796543 Free PMC article. Updated. Review.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources